Dual targeting of the androgen receptor and <scp>PI3K</scp> / <scp>AKT</scp> / <scp>mTOR</scp> pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis
Tatsuo Sugawara(Bayer (Germany)), Bernard Haendler(Bayer (Germany))
Cited by 20